Tonghua Dongbao Pharmaceutical Statistics

Total Valuation

Tonghua Dongbao Pharmaceutical has a market cap or net worth of CNY 15.02 billion. The enterprise value is 14.87 billion.

Market Cap	15.02B
Enterprise Value	14.87B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 23, 2024

Share Statistics

Tonghua Dongbao Pharmaceutical has 1.98 billion shares outstanding. The number of shares has decreased by -3.98% in one year.

Shares Outstanding	1.98B
Shares Change (YoY)	-3.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.13%
Owned by Institutions (%)	13.40%
Float	1.18B

Valuation Ratios

The trailing PE ratio is 32.30 and the forward PE ratio is 16.30. Tonghua Dongbao Pharmaceutical's PEG ratio is 1.48.

PE Ratio	32.30
Forward PE	16.30
PS Ratio	5.97
PB Ratio	2.31
P/FCF Ratio	66.12
PEG Ratio	1.48

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.54, with an EV/FCF ratio of 65.47.

EV / Earnings	32.87
EV / Sales	6.07
EV / EBITDA	16.54
EV / EBIT	20.83
EV / FCF	65.47

Financial Position

The company has a current ratio of 4.99, with a Debt / Equity ratio of 5.53.

Current Ratio	4.99
Quick Ratio	2.77
Debt / Equity	5.53
Debt / EBITDA	0.40
Debt / FCF	1.58
Interest Coverage	66.57

Financial Efficiency

Return on equity (ROE) is 6.94% and return on invested capital (ROIC) is 6.63%.

Return on Equity (ROE)	6.94%
Return on Assets (ROA)	6.43%
Return on Capital (ROIC)	6.63%
Revenue Per Employee	766,297
Profits Per Employee	141,597
Employee Count	3,196
Asset Turnover	0.35
Inventory Turnover	0.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.61% in the last 52 weeks. The beta is 0.21, so Tonghua Dongbao Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-21.61%
50-Day Moving Average	7.93
200-Day Moving Average	9.65
Relative Strength Index (RSI)	39.92
Average Volume (20 Days)	10,987,146

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tonghua Dongbao Pharmaceutical had revenue of CNY 2.45 billion and earned 452.54 million in profits. Earnings per share was 0.23.

Revenue	2.45B
Gross Profit	1.94B
Operating Income	713.93M
Pretax Income	503.70M
Net Income	452.54M
EBITDA	899.04M
EBIT	713.93M
Earnings Per Share (EPS)	0.23

Full Income Statement

Balance Sheet

The company has 512.40 million in cash and 359.00 million in debt, giving a net cash position of 153.40 million or 0.08 per share.

Cash & Cash Equivalents	512.40M
Total Debt	359.00M
Net Cash	153.40M
Net Cash Per Share	0.08
Equity (Book Value)	6.50B
Book Value Per Share	3.28
Working Capital	1.62B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 667.48 million and capital expenditures -440.29 million, giving a free cash flow of 227.19 million.

Operating Cash Flow	667.48M
Capital Expenditures	-440.29M
Free Cash Flow	227.19M
FCF Per Share	0.11

Full Cash Flow Statement

Margins

Gross margin is 79.01%, with operating and profit margins of 29.15% and 18.48%.

Gross Margin	79.01%
Operating Margin	29.15%
Pretax Margin	20.57%
Profit Margin	18.48%
EBITDA Margin	36.71%
EBIT Margin	29.15%
FCF Margin	9.28%

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 3.30%.

Dividend Per Share	0.25
Dividend Yield	3.30%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	n/a
Payout Ratio	110.45%
Buyback Yield	3.98%
Shareholder Yield	7.28%
Earnings Yield	3.09%
FCF Yield	1.51%

Dividend Details

Stock Splits

The last stock split was on May 25, 2018. It was a forward split with a ratio of 1.2.

Last Split Date	May 25, 2018
Split Type	Forward
Split Ratio	1.2